Illumina Historical Balance Sheet

ILMN Stock

USD 87.66 2.87 3.38%

Trend analysis of Illumina balance sheet accounts such as Other Current Liabilities of 762.3 M or Total Current Liabilities of 1.6 B provides information on Illumina's total assets, liabilities, and equity, which is the actual value of Illumina to its prevalent stockholders. By breaking down trends over time using Illumina balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Illumina latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Illumina is a good buy for the upcoming year.

Illumina Inventory

574.35 Million

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

About Illumina Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Illumina at a specified time, usually calculated after every quarter, six months, or one year. Illumina Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Illumina and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Illumina currently owns. An asset can also be divided into two categories, current and non-current.

Illumina Balance Sheet Chart

At this time, Illumina's Non Currrent Assets Other are very stable compared to the past year. As of the 22nd of March 2025, Cash And Short Term Investments is likely to grow to about 1.2 B, while Total Assets are likely to drop about 4.1 B.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Illumina assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Illumina books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Illumina balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Illumina are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Illumina's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Illumina current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.At this time, Illumina's Non Currrent Assets Other are very stable compared to the past year. As of the 22nd of March 2025, Cash And Short Term Investments is likely to grow to about 1.2 B, while Total Assets are likely to drop about 4.1 B.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	3.5B	2.3B	2.5B	2.7B
Total Assets	12.3B	10.1B	6.3B	4.1B

Short Long Term Debt Total Total Assets

Illumina balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Other Liab	Current Deferred Revenue
Total Assets		0.8	0.57	0.69	0.98	0.88	0.52	0.57	0.91	0.72	0.96	0.76	0.34	0.74	0.51	-0.11	0.88	0.77	0.71	0.85	0.61	0.39	0.84	0.55	0.74	0.69
Short Long Term Debt Total	0.8		0.86	0.93	0.7	0.9	0.77	0.17	0.92	0.7	0.72	0.87	0.34	0.93	0.58	-0.16	0.9	0.89	0.76	0.98	0.6	0.67	0.65	0.58	0.85	0.93
Other Current Liab	0.57	0.86		0.83	0.44	0.73	0.81	-0.24	0.76	0.43	0.56	0.7	0.01	0.89	0.43	-0.42	0.8	0.73	0.83	0.88	0.3	0.48	0.62	0.41	0.8	0.88
Total Current Liabilities	0.69	0.93	0.83		0.56	0.79	0.74	0.08	0.82	0.63	0.6	0.8	0.35	0.81	0.46	-0.07	0.72	0.85	0.66	0.91	0.58	0.86	0.6	0.47	0.71	0.82
Total Stockholder Equity	0.98	0.7	0.44	0.56		0.83	0.42	0.66	0.85	0.66	0.95	0.69	0.32	0.65	0.42	-0.09	0.83	0.69	0.65	0.76	0.55	0.26	0.82	0.46	0.69	0.6
Property Plant And Equipment Net	0.88	0.9	0.73	0.79	0.83		0.52	0.46	0.92	0.82	0.77	0.8	0.48	0.9	0.48	-0.04	0.89	0.8	0.63	0.91	0.72	0.49	0.63	0.53	0.78	0.88
Net Debt	0.52	0.77	0.81	0.74	0.42	0.52		-0.29	0.71	0.1	0.59	0.75	-0.21	0.7	0.35	-0.46	0.7	0.66	0.86	0.77	0.05	0.51	0.63	0.31	0.82	0.76
Retained Earnings	0.57	0.17	-0.24	0.08	0.66	0.46	-0.29		0.36	0.61	0.43	0.22	0.68	0.14	0.23	0.51	0.26	0.17	-0.14	0.19	0.66	0.08	0.19	0.3	0.06	0.08
Accounts Payable	0.91	0.92	0.76	0.82	0.85	0.92	0.71	0.36		0.66	0.86	0.9	0.29	0.91	0.55	-0.19	0.95	0.83	0.77	0.96	0.56	0.49	0.74	0.58	0.9	0.9
Cash	0.72	0.7	0.43	0.63	0.66	0.82	0.1	0.61	0.66		0.53	0.52	0.76	0.65	0.54	0.25	0.64	0.66	0.26	0.68	0.89	0.5	0.38	0.62	0.4	0.57
Non Current Assets Total	0.96	0.72	0.56	0.6	0.95	0.77	0.59	0.43	0.86	0.53		0.72	0.07	0.66	0.37	-0.35	0.87	0.75	0.82	0.8	0.35	0.26	0.93	0.4	0.78	0.63
Non Currrent Assets Other	0.76	0.87	0.7	0.8	0.69	0.8	0.75	0.22	0.9	0.52	0.72		0.22	0.81	0.41	-0.18	0.83	0.76	0.7	0.88	0.46	0.59	0.6	0.45	0.89	0.85
Cash And Short Term Investments	0.34	0.34	0.01	0.35	0.32	0.48	-0.21	0.68	0.29	0.76	0.07	0.22		0.32	0.48	0.82	0.18	0.2	-0.26	0.28	0.93	0.47	-0.12	0.54	-0.02	0.25
Net Receivables	0.74	0.93	0.89	0.81	0.65	0.9	0.7	0.14	0.91	0.65	0.66	0.81	0.32		0.59	-0.16	0.92	0.73	0.73	0.94	0.58	0.46	0.56	0.61	0.86	0.98
Common Stock Shares Outstanding	0.51	0.58	0.43	0.46	0.42	0.48	0.35	0.23	0.55	0.54	0.37	0.41	0.48	0.59		0.23	0.58	0.37	0.33	0.57	0.63	0.27	0.27	0.98	0.41	0.52
Short Term Investments	-0.11	-0.16	-0.42	-0.07	-0.09	-0.04	-0.46	0.51	-0.19	0.25	-0.35	-0.18	0.82	-0.16	0.23		-0.33	-0.32	-0.63	-0.23	0.61	0.22	-0.5	0.28	-0.43	-0.21
Non Current Liabilities Total	0.88	0.9	0.8	0.72	0.83	0.89	0.7	0.26	0.95	0.64	0.87	0.83	0.18	0.92	0.58	-0.33		0.8	0.85	0.94	0.47	0.32	0.77	0.59	0.91	0.89
Other Current Assets	0.77	0.89	0.73	0.85	0.69	0.8	0.66	0.17	0.83	0.66	0.75	0.76	0.2	0.73	0.37	-0.32	0.8		0.74	0.88	0.44	0.64	0.72	0.38	0.74	0.76
Other Stockholder Equity	0.71	0.76	0.83	0.66	0.65	0.63	0.86	-0.14	0.77	0.26	0.82	0.7	-0.26	0.73	0.33	-0.63	0.85	0.74		0.82	0.06	0.27	0.88	0.3	0.86	0.72
Total Liab	0.85	0.98	0.88	0.91	0.76	0.91	0.77	0.19	0.96	0.68	0.8	0.88	0.28	0.94	0.57	-0.23	0.94	0.88	0.82		0.56	0.6	0.75	0.58	0.89	0.92
Total Current Assets	0.61	0.6	0.3	0.58	0.55	0.72	0.05	0.66	0.56	0.89	0.35	0.46	0.93	0.58	0.63	0.61	0.47	0.44	0.06	0.56		0.54	0.16	0.7	0.27	0.51
Short Term Debt	0.39	0.67	0.48	0.86	0.26	0.49	0.51	0.08	0.49	0.5	0.26	0.59	0.47	0.46	0.27	0.22	0.32	0.64	0.27	0.6	0.54		0.25	0.29	0.36	0.49
Intangible Assets	0.84	0.65	0.62	0.6	0.82	0.63	0.63	0.19	0.74	0.38	0.93	0.6	-0.12	0.56	0.27	-0.5	0.77	0.72	0.88	0.75	0.16	0.25		0.25	0.69	0.52
Common Stock	0.55	0.58	0.41	0.47	0.46	0.53	0.31	0.3	0.58	0.62	0.4	0.45	0.54	0.61	0.98	0.28	0.59	0.38	0.3	0.58	0.7	0.29	0.25		0.42	0.54
Other Liab	0.74	0.85	0.8	0.71	0.69	0.78	0.82	0.06	0.9	0.4	0.78	0.89	-0.02	0.86	0.41	-0.43	0.91	0.74	0.86	0.89	0.27	0.36	0.69	0.42		0.89
Current Deferred Revenue	0.69	0.93	0.88	0.82	0.6	0.88	0.76	0.08	0.9	0.57	0.63	0.85	0.25	0.98	0.52	-0.21	0.89	0.76	0.72	0.92	0.51	0.49	0.52	0.54	0.89

Click cells to compare fundamentals

Illumina Account Relationship Matchups

Illumina balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	7.6B	15.2B	12.3B	10.1B	6.3B	4.1B
Short Long Term Debt Total	1.9B	2.5B	3.5B	2.3B	2.5B	2.7B
Other Current Liab	236M	358M	814M	908M	726M	762.3M
Total Current Liabilities	1.2B	1.1B	2.8B	1.6B	1.5B	1.6B
Total Stockholder Equity	4.7B	10.7B	6.6B	5.7B	2.4B	2.3B
Property Plant And Equipment Net	1.5B	1.7B	1.7B	1.6B	1.2B	1.3B
Net Debt	45M	1.2B	1.5B	1.2B	1.4B	1.5B
Retained Earnings	4.7B	5.5B	1.1B	(19M)	(1.2B)	(1.2B)
Accounts Payable	192M	332M	293M	245M	221M	232.1M
Cash	1.8B	1.2B	2.0B	1.0B	1.1B	694.8M
Non Current Assets Total	3.1B	12.5B	8.7B	7.5B	3.6B	2.2B
Non Currrent Assets Other	171M	445M	423M	217M	348M	365.4M
Cash And Short Term Investments	3.5B	1.3B	2.0B	1.1B	1.2B	1.2B
Net Receivables	487M	648M	688M	752M	735M	771.8M
Short Term Investments	1.7B	107M	26M	6M	93M	88.4M
Liabilities And Stockholders Equity	7.6B	15.2B	12.3B	10.1B	6.3B	4.1B
Non Current Liabilities Total	1.6B	3.4B	2.9B	2.8B	2.4B	2.5B
Other Current Assets	290M	295M	536M	216M	244M	256.2M
Other Stockholder Equity	(33M)	5.2B	5.5B	5.8B	3.6B	3.8B
Total Liab	2.9B	4.5B	5.7B	4.4B	3.9B	4.1B
Total Current Assets	4.5B	2.7B	3.6B	2.6B	2.7B	1.8B
Accumulated Other Comprehensive Income	5M	2M	17M	3M	22M	23.1M
Short Term Debt	562M	71M	1.3B	86M	499M	524.0M
Intangible Assets	142M	3.3B	3.3B	3.0B	295M	512.3M
Other Liab	202M	303M	915M	649M	746.4M	783.7M
Current Deferred Revenue	186M	234M	245M	252M	289.8M	304.3M
Other Assets	179M	609M	445M	212M	243.8M	133.6M
Long Term Debt	673M	1.7B	1.5B	1.5B	1.5B	809.0M
Inventory	372M	431M	568M	587M	547M	574.4M
Property Plant And Equipment Gross	1.5B	1.7B	1.7B	2.7B	2.5B	2.6B
Property Plant Equipment	889M	922M	1.7B	1.1B	1.3B	1.3B
Good Will	897M	7.1B	3.2B	2.5B	1.1B	1.2B
Treasury Stock	(2.6B)	(3.0B)	(3.8B)	(3.7B)	(3.3B)	(3.2B)
Net Tangible Assets	4.3B	4.3B	377M	4.1B	4.7B	4.9B
Retained Earnings Total Equity	4.1B	4.7B	5.5B	1.1B	1.3B	2.0B

Pair Trading with Illumina

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.

Moving together with Illumina Stock

0.78	EYEN	Eyenovia	Pair Corr
0.77	MOLN	Molecular Partners	Pair Corr

Moving against Illumina Stock

0.93	LUCD	Lucid Diagnostics	Pair Corr
0.92	CPIX	Cumberland Pharmaceuticals	Pair Corr
0.84	CMRX	Chimerix	Pair Corr
0.84	INMD	InMode	Pair Corr
0.79	FNA	Paragon 28	Pair Corr

The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.

The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:

How To Invest In Illumina

Details

Is Illumina Stock a good investment?

Details

What is Illumina's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.96)

Earnings Share

(7.95)

Revenue Per Share

27.497

Quarterly Revenue Growth

(0.02)

Return On Assets

0.0264

The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Illumina Historical Balance Sheet

Illumina Inventory

574.35 Million

About Illumina Balance Sheet Analysis

Illumina Balance Sheet Chart

Total Assets

Total Current Liabilities

Illumina balance sheet Correlations

Illumina Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Illumina balance sheet Accounts

Pair Trading with Illumina

Moving together with Illumina Stock

Moving against Illumina Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.98	Total Assets
Total Liab	+ 0.98	Short Long Term Debt Total
Current Deferred Revenue	+ 0.98	Net Receivables
Common Stock	+ 0.98	Common Stock Shares Outstanding
Non Current Assets Total	+ 0.96	Total Assets
Total Liab	+ 0.96	Accounts Payable

Other Stockholder Equity	- 0.63	Short Term Investments
Intangible Assets	- 0.5	Short Term Investments
Short Term Investments	- 0.46	Net Debt
Other Liab	- 0.43	Short Term Investments
Short Term Investments	- 0.42	Other Current Liab
Short Term Investments	- 0.35	Non Current Assets Total